NewLimit Blog

Home
Archive
About
NewLimit secures $40 million in venture funding from Dimension Capital, Founders Fund, Kleiner Perkins and other investors
NewLimit works across cell biology, genomics, machine learning, and cellular reprogramming to treat diseases and reverse aging
 • 
Brian Armstrong
, 
Blake Byers
, 
Greg Johnson
, and 
Jacob C. Kimmel
New
Top
April 2023 Progress Update
Overcoming a primary challenge
 • 
Jacob C. Kimmel
March 2023 Progress Update - Live Event!
This time with live video
 • 
Jacob C. Kimmel
 and 
Brian Armstrong
February 2023 Progress Update
Screening at scale
 • 
Jacob C. Kimmel
January 2023 Update
Bridging Atoms and Bits
 • 
Greg Johnson
December 2022 Progress Update
(Calendar) Year in Review
 • 
Jacob C. Kimmel
November 2022 Progress Update
Arrival at the starting line
 • 
Jacob C. Kimmel
October 2022 Progress Update
Experiments in initialization
 • 
Jacob C. Kimmel
NewLimit Blog
NewLimit Blog
Updates on our progress toward radical extension of human healthspan

NewLimit Blog

AboutArchiveSitemap
© 2023 NewLimit Inc.
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing